Reactions Weekly

, Volume 1658, Issue 1, pp 351–351 | Cite as

Nivolumab

Hepatotoxicity: case report
Case report
  • 25 Downloads

Reference

  1. Sotelo M, et al. Nivolumab beyond first-line (1L) treatment in metastatic non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology 12: S1340-S1341 abstr. P3.02c-100, No. 1, Jan 2017. Available from: URL: http://www.jto.org/article/S1556-0864(16)33137-9/fulltext [abstract] - Spain

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations